Playback speed
10 seconds
EHA® 2023 Insights: "Preliminary Results From the Ph1/2 RUBY Trial of EDIT-301 in Patients With Severe Sickle Cell Disease Using Highly Specific and Efficient ASCAS12A Enzyme"
By
Insights from 2023 EHA® Annual Meeting
FEATURING
Rabi Hanna
By
Insights from 2023 EHA® Annual Meeting
FEATURING
Rabi Hanna
0 views
June 23, 2023
Comments 0
Login to view comments.
Click here to Login